These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16026120)

  • 1. Atherosclerosis and innate immune signaling.
    Laberge MA; Moore KJ; Freeman MW
    Ann Med; 2005; 37(2):130-40. PubMed ID: 16026120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR signaling: an emerging bridge from innate immunity to atherogenesis.
    Michelsen KS; Doherty TM; Shah PK; Arditi M
    J Immunol; 2004 Nov; 173(10):5901-7. PubMed ID: 15528321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.
    Tobias P; Curtiss LK
    J Lipid Res; 2005 Mar; 46(3):404-11. PubMed ID: 15654120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role for toll-like receptors in atherosclerosis and arterial remodeling.
    Vink A; de Kleijn DP; Pasterkamp G
    Curr Opin Lipidol; 2004 Oct; 15(5):515-21. PubMed ID: 15361786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do macrophage innate immune receptors enhance atherogenesis?
    Gordon S
    Dev Cell; 2003 Nov; 5(5):666-8. PubMed ID: 14602065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response.
    Murillo LS; Morré SA; Peña AS
    Drugs Today (Barc); 2003 Jun; 39(6):415-38. PubMed ID: 12944995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor signaling pathways.
    Barton GM; Medzhitov R
    Science; 2003 Jun; 300(5625):1524-5. PubMed ID: 12791976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.
    Shuto T; Xu H; Wang B; Han J; Kai H; Gu XX; Murphy TF; Lim DJ; Li JD
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8774-9. PubMed ID: 11438700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
    Hajishengallis G; Sharma A; Russell MW; Genco RJ
    Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity and toll-like receptors: clinical implications of basic science research.
    Abreu MT; Arditi M
    J Pediatr; 2004 Apr; 144(4):421-9. PubMed ID: 15069387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.
    Michelsen KS; Wong MH; Shah PK; Zhang W; Yano J; Doherty TM; Akira S; Rajavashisth TB; Arditi M
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10679-84. PubMed ID: 15249654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low density lipoprotein and innate immune receptors.
    Miller YI; Chang MK; Binder CJ; Shaw PX; Witztum JL
    Curr Opin Lipidol; 2003 Oct; 14(5):437-45. PubMed ID: 14501582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways.
    Björkbacka H; Kunjathoor VV; Moore KJ; Koehn S; Ordija CM; Lee MA; Means T; Halmen K; Luster AD; Golenbock DT; Freeman MW
    Nat Med; 2004 Apr; 10(4):416-21. PubMed ID: 15034566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.
    Kobayashi K; Inohara N; Hernandez LD; Galán JE; Núñez G; Janeway CA; Medzhitov R; Flavell RA
    Nature; 2002 Mar; 416(6877):194-9. PubMed ID: 11894098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappa B activation and innate immune response in microbial pathogen infection.
    Naumann M
    Biochem Pharmacol; 2000 Oct; 60(8):1109-14. PubMed ID: 11007948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors as sensors of pathogens.
    Hallman M; Rämet M; Ezekowitz RA
    Pediatr Res; 2001 Sep; 50(3):315-21. PubMed ID: 11518816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Toll-receptor family and control of innate immunity.
    Kopp EB; Medzhitov R
    Curr Opin Immunol; 1999 Feb; 11(1):13-8. PubMed ID: 10047546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity via Toll-like receptors and Nod proteins.
    Athman R; Philpott D
    Curr Opin Microbiol; 2004 Feb; 7(1):25-32. PubMed ID: 15036136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines.
    Farina C; Theil D; Semlinger B; Hohlfeld R; Meinl E
    Int Immunol; 2004 Jun; 16(6):799-809. PubMed ID: 15096475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.